Plain-English translation of NCT06720272 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a dedicated school nurse program can help prevent rheumatic heart disease in children living in areas where this condition is common. The program focuses on educating children about the disease, identifying throat infections caused by group A streptococcal bacteria (which can lead to rheumatic heart disease), and ensuring children receive proper treatment and follow-up care.
Rheumatic heart disease is a serious condition that develops in children after untreated or poorly treated throat infections, and it remains a major cause of heart disease in developing countries. This trial aims to see whether catching and treating these infections early through a school-based program can prevent the disease from developing in the first place.
You likely qualify if…
You likely don't qualify if…
If you are selected for the school nurse program, you would receive health education about rheumatic heart disease at your school and be screened for throat infections by the school nurse. If you have a throat infection, you would receive treatment and follow-up visits to make sure you recover properly. The exact timing of when your school joins the program will vary, but the goal is to provide ongoing support throughout the school year.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Nepal
Zambia
Sponsor
Thomas Pilgrim
Collaborators
Centre for Infectious Disease Research in Zambia, National Academy of Medical Sciences, Nepal
Enrollment target
~6,000 participants
Started
December 2024
Primary completion
February 2028
Age range
5 Years – 16 Years
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Thomas Pilgrim Bern University Hospital, Bern, Switzerland
Thomas Pilgrim
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.